Texas Hospice Valuation Multiples in 2026
A Texas-focused look at hospice valuation multiples in 2026. Learn what buyers are paying, how EBITDA drives value, and what Texas business owners can do to protect and increase their…
Read MoreCategory: Blog Posts
Hospice Valuation Multiples Report (US Market Averages)
A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home…
Read More
Hospice EBITDA Valuation Benchmarks
Learn how hospice EBITDA multiples are set in today’s market—what drives the multiple, how compliance affects value, and how owners can prepare to maximize price.
Read More
A Hospice Owner’s Guide to Valuation Multiples: What Drives Price
A step-by-step hospice owner’s guide to valuation multiples: how buyers think, what to prepare, how to avoid exit pitfalls, and protect your sale price.
Read More
Hospice Multiples Fees & Exit Planning (US)
Straight answers for hospice owners on multiples, valuation methods, compliance risk, buyer diligence, and what a professional hospice valuation typically costs.
Read More
Top 10 Questions to Ask an Advisor Before Getting a Hospice Valuation
Getting a hospice valuation is more than a number — it shapes your exit timing, buyer confidence, and deal terms. Here are 10 questions every hospice owner should ask an…
Read More
What the New CMS Rules Mean for Home Health Providers — And How They Impact Your Agency’s Valuation in 2026 & Beyond
Home health and hospice owners are facing major CMS changes—from the new Team Model to MedPAC’s proposed 7% payment cut. These shifts directly influence valuation, buyer appetite, and the timing…
Read MoreClosing? Why Healthcare Sellers Are Facing Longer Timelines & How to Stay in Control of Your Exit
Closing is taking longer than ever for healthcare agency sales—often 9–10+ months—but that doesn’t mean sellers are powerless. This guide explains why timelines have stretched, what really slows deals down,…
Read More
Hospice Valuation amid Policy Shifts: What Owners Need to Know
Discover how Vallexa Advisors is redefining hospice and healthcare valuations with precision, global reach, and integrity. Whether you’re selling a hospice, home health, or senior-care business, our team helps you…
Read More
How the 2026 Final Rule and HOPE Tool Shape Hospice Valuation
The 2026 Final Rule and HOPE Tool are reshaping how hospice valuations are calculated. Learn how quality metrics, compliance, and data transparency affect your agency’s value — and how Vallexa…
Read More
Hospice Valuation: Understanding the Process and Maximizing Your Agency’s Worth
Discover how hospice valuations are determined and what truly drives your agency’s worth. Learn the factors buyers consider — from EBITDA to compliance — and how Vallexa Advisors helps hospice…
Read More
Comprehensive Guide to Selling Senior Healthcare Businesses: Assisted Living, Hospice, Home Health & More
Thinking of selling your assisted living, RCFE, hospice, home health or skilled nursing business? Learn current valuation ranges, key drivers and steps to maximize value. Vallexa Advisors guides healthcare owners…
Read More
How to Sell a Home Health Care Business: Your Roadmap to Maximum Value with Vallexa Advisors
If you’re ready to sell a home health care business, partner with Vallexa Advisors. We specialize in home health business valuation, appraisal and sale—from “sell my home health agency” to…
Read More
Hospice Valuation in 2025: Why Big Buyers Are Sitting Out & Why You Need Vallexa to Sell Your Hospice Business
Hospice valuation is under pressure, and big buyers are stepping back. If you’re ready to sell your hospice business, the right specialist matters. Vallexa Advisors guides you through hospice appraisal,…
Read More
Hospice Valuation: How to Accurately Value and Maximize Worth of a Hospice Business
Hospice valuation is where compassion meets numbers. Learn how buyers price hospice agencies, what drives multiples, and how Vallexa Advisors helps owners prepare, position, and sell for premium value with…
Read More